Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
imo...you are quite correct...and we know RBl and PHRI...continue to test to enrich data of Brilacidin's ability to resolve Covid-19, pre and post infection. Those test continue until end of August...
The last release from RBL ... appears to be an "interim" test results report, with more coming from it and from the PHRI (GMU)... IMNO...stay tuned for more supporting data for the FDA IND application, as well as emergency use authorization.
"Ongoing laboratory testing conducted at a U.S. Regional Biocontainment Laboratory (RBL), and at a Public Health Research Institute (PHRI), supports Brilacidin’s antiviral ability to safely inhibit SARS-CoV-2 in both human and animal cell lines."
http://www.ipharminc.com/press-release/2020/8/4/innovation-pharmaceuticals-and-us-regional-biocontainment-laboratory-nearing-completion-of-brilacidin-anti-sars-cov-2-covid-19-in-vitro-testing
back from short vacation...IMO company already knew the new product would be ready from MFG before the end of or beginning of 4th Q...in order to make announcement of planned 4th Q Human Trials plan.
Yeah Leo... ignore the FDA, ignore trials , ignore process ... that will get us far!
...washing up on the shores of Long Island a frequent occurrence during summer months... in on the beach in Southampton for a couple of days and will have to look out for them. Storms usually kick them up ... maybe tomorrow?
The application sited in PR was Grant Application with GWU lab... also co referenced transmitting info and updates to BARDA ...
IMO... it was a news leak... maybe get it Wednesday
Also news was not there today... yet rose significantly ...
... the reason why we will rise again tomorrow... we will likely learn tomorrow
Meanwhile we had good accumulation today... curious why? You should be???
One mans wall is another mans stepping platform higher!
Did it dawn on you there might be a reason for SP higher ...with no news???
The problem with EIND single use authorization is that the company has no control or sufficient means to verify and confirm the condition of patient for c"control" purposes. The results of the use must be incorporated into sanctioned FDA IND Humsn trials and if inaccurately reported could skew results of the larger trial ( if many EIN ) or dissuade Trials
Leo has categorically turned down numerous individual INDs for that reason. I sent him one from Two Doctors from India who were working in a major hospital treating patients. They ended up pulling out with hydroxychloroquine and antibiotics
... I concur with Farrell... and would note...The "Sales Pitch" are the published FACTS and Final DATA from the two RBL ... the continuation of the "Sales Pitch" will be the reporter results to the FDA on clinical trials.
A great deal of "free" and pervasive publicity on Brilacidin's "wipe-out" of Remdesivir will emerge and IMO, with very big people behind The reporting.
In short... substance over form will rule the day!
...I would not exempt him...but if it happened I would hope participation would be behind the scenes...stealth!
...I believe you are making two incorrect assumptions~
...they can choose to comply or leave... If it happened...IMO they would comply with a smile...profit is incorporated into the orders
lol...just about ...every potential vaccine has shown "some positive results"...It a joke...
A VACCINE IS NOT THE ANSWER...the vaccines being developed don't "wipe out" and destroy the virus in an infected patient (even Gates admitted it) ... A THERAPEUTIC which destroys IS the ANSWER!
Think B
its U.S subsidiaries/facilities... I believe that they have 8 locations in the U.S.
The most reliable...now. Are you suggesting the NYT rag reliable?
...it means that it all takes time...what do you expect with a bureaucracy
IMO...I would place my bet on an IND being submitted
frankly...I would not either...he wants to own everything on the cheap (or in exchange for grants) I say BS to that!
...imo...he (or his staff which reviews and issues grant requests) don't need to be informed...Not implying that a grant request was submitted by IPIX...but it would be my belief that they know of Brilacidin by now...and likely looking into it. Too much smoke already out on Brilacidin...not to be picked up.
attilla... I agree with your observation and concur with your conclusion...the problem (for some) investors is what you identify...patience
imo..slow and steady investors will win the race...
...its not what I "say" ... its what Trialsite news reported...also I remember it was brought up at the time of Fauci's great announcement...of showing promise reducing stay from 15 to 11 days.
IMO...Gilead management is being watched...very very closely...as well as its surrogates of Gilead... I would not be surprised to see some very powerful people (other than DJT) getting behind Brilacidin.
Love to see DOJ (or even Judicial Watch) open an investigation...looking at Gilead and Hydroxychloroquine disinformation campaign.
But yes...with the Billions involved...the corruption is becoming more pervasive, blatant and in the open. (and we have no press to point it out either)...
Bill Gates...in recently making the case for inferior Remdesivir, is actually making a strong case for Brilacidin, (far superior to Remdesivir)..but he apparently doesn't know it yet.
The article below lays it out.
Our need for Therapeutics is far greater than the need for "iffy" vaccines.
Gates's #1 therapeutic is Remdesivir...a drug that failed and continued to fail in curtailing deaths due to Covid-19 infection. Its' test criteria was altered when it became clear toward the end of its trial that it would fail to meet the Mortality Criteria "end points" for which the test was set up. ( https://www.trialsitenews.com/the-remdesivir-ride-what-you-see-is-what-you-get/ ;). New criteria lessening time for hospital stays. (from 15 to 11 days in milder cases became the new efficacy measurement, then "voila"...$3,000 per patient treatments approved!
Gates is right about Vaccines:
1. They won't protect against the virus anytime soon
2. They will not be highly protective. (not 100% effective in prevention)
3. They take months or even years to develop
4. They won't protect those who are already infected.
5. There is still a great deal of resistance to taking them...esp. with Children (added)
That is why Gates now more "excited" and has put his efforts into Therapeutics:
1. They are much easier to test...(days, weeks...not months, years)
2. If efficacious...results are more immediately seen.
3. Therapeutics will make a big difference in high risk populations where the majority of deaths occur...i.e Nursing Homes
His top therapeutic is Remdesivir...inferring that the cutting down of hospitalization of Covid-19 infected patients from 15 days to 11 days equates to a potential reduction in mortality of 62%. But Gilead's claim is still to be proven. Its original test demonstrated 0% mortality prevention.
So if the Remdesivir IV is the "miracle therapeutic" with a 50% (in tests) viral reduction....what is Brilacidin with up to a proven 97% (in tests) viral reduction? And that is without increasing dosages, which Gilead cannot with Remdesivir due to its toxicity, while Brilacidin can because of its NON-Toxicity.
At the very least...Gates has made a cogent and far stronger case for the superior Brilacidin...but he doesn't know it yet.
P.S Expect even a greated case for Brilacidin, as more data to arrive from the RBL continued testing and researchers from both government labs present Peer Review Articles on findings.
https://www.yahoo.com/news/bill-gates-says-3-coronavirus-185500502.html
Bill Gates isn't expecting a highly protective coronavirus vaccine to be ready anytime soon."The very first vaccine won't be like a lot of vaccines, where it's a 100% transmission-blocking and 100% avoids the person who gets the vaccine getting sick," the billionaire philanthropist told Insider.Vaccine trials take months, they don't have to create completely effective inoculations, and they won't help protect people who are already sick.Related: How Bill Gates and Warren Buffett are changing the worldThat's why Gates is more excited, in the immediate term, about coronavirus therapeutics. "It's much easier to test a therapeutic than it is a vaccine," he said during a wide-ranging chat earlier this week. His best guess is that there are three types of therapeutic treatments that could be available for coronavirus patients in just a "few months."It's not quite a reason to herald the end of the pandemic, but it's a start."It doesn't let you go to sporting events or hang out at the bars," he said. "You gotta get herd immunity [through vaccination] before you really do that."But these treatments, if shown effective at helping people recover faster and better from the virus, could be a game changer for the mounting coronavirus death toll. Already, more than 150,000 people are dead from the coronavirus in the US. Several estimates suggest about 40% of those deaths are linked to nursing homes. "These things where nursing homes get infected, and very high death rates, the therapeutics will make a big difference there," he said.Here's a breakdown of the three kinds of treatments Gates is most excited about. Antiviral drugs Remdesivir2 by Getty ImagesVials of Remdesivir.Ulrich Perrey/Pool/AFP/Getty ImagesAntivirals (as the name suggests) aim to act against a virus. They do this by preventing the virus from multiplying and reproducing. (The antiviral Tamiflu, for example, can help make flu infections shorter and less severe, if taken early on.)One antiviral drug being used right now to treat the coronavirus is Remdesivir, a broad-spectrum antiviral and once failed Ebola treatment. Studies suggest it helps shorten coronavirus recovery time in patients who are very ill. In the US, Remdesivir is recommended only for emergency use in hospitals (it's approved in Japan). It is delivered intravenously. Remdesivir maker Gilead announced on July 10 that its early trial results suggest the drug may cut hospitalized patients' risk of death by 62%, when compared with the standard of care, calling it "an important finding that requires confirmation." More research on the drug is being conducted on thousands more hospitalized coronavirus patients, with results expected "in the coming months," the company said in a release....
...only thing I have heard from DD outside co...is that very recently...someone rather big...is very interested in wanting more info on the Rem vs. Brilacidin development...
Lots of Gov. $ thrown at Rem...and its expensive per treatment ($3,000 a dose) Is gov getting ripped off? ...Do you think that it is Trumps belief that they are? ...
Might be in the bullseye of pharmacy drug pricing issue?
We know B is relatively inexpensive ... to produce. We have no $ for dosage cost or administering costs.
Maybe news on it from outside IPIX could come?
IMO I spec. that there could be...reading the tea leaves...
Might even be a point in time where Gilead might be concerned about allegations of manipulating the market by actively funding a disinformation campaign about Hydroxychloroquine.
Is 13% drop ($10) by GILD in 10 days a coincidence or is heat on the way?
Was Cramer's (a huge fan of GILD) warning on his Pre-Market show...to President Trump on CNBC yesterday AM about fighting the BP on drug pricing before the election stating:
...so true Warren IMO...REM. is garbage...with all the $ behind it...never approved for us...until now and very limited... a drug barely demonstrating efficacy.
Wait until a head to head comparison comes out with Brilacidin...B will blow it away...RBL tests have already shown that...when DIRECT is "published"... shorts watch out!
referring to LEO being fraudulent...actionable You are asserting a statement of FACT!
There is none of course...just the opposite
Next you will be calling U.S. RBL results a Fraud...LOL
Watch out for what you post...it is actionable against you!!!
Flippers are at .25... going to make them give me their shares at .235~
...Dr Mark Siegel is a very good connection also...has his ear.
"personally"...I prefer Rudy Giuliani as a conduit...has his ear more often and has done Covid-19 podcasts..."ya never know!"
imo...the final liquidation by MFO took place between $.40-$.60...and they are clearly gone as per Press Release cited.
GMU...researcher was focused on Remdesivir...then got Brilacidin...only natural that an easy synergy/comparison could be determined/made.
...it said 7/20 "RBL staff and the Company are considering conducting in vitro experiments to assess such potential synergistic effects (Remdesivir/Brilacidin). No assurances are made or implied that such combination studies will be conducted.
...More detailed data, based on the ongoing (post 7/20) antiviral testing being conducted at the RBL....August
From 7/7 PR...MFO gone!...there is NO DEATH-SPIRAL FINANCING:
"The Company also reports that all preferred shares and warrants previously allotted as part of a financing arrangement have been exercised, establishing a cash balance of approximately $6 Million as of June 30, 2020."
...but there are habitual flippers...
From 7/7 PR...MFO gone!:
"The Company also reports that all preferred shares and warrants previously allotted as part of a financing arrangement have been exercised, establishing a cash balance of approximately $6 Million as of June 30, 2020."
...very correct!
IMO...with GMU still doing testing on Brilacidin, and having done extensive testing of Remdesivir...(I believe the PR said until end of August)...and if they happen to continue down the road of doing an "in depth" comparison between Brilacidin to Remdesivir...
...B will blow away R...and you will not have to worry about..."We go Down"
That "blow away" reported by an RBL ... will turn MAJOR heads!
IMO...a very possible scenario
...the kitchen sink is usually thrown in at the end as negotiating tactics. You have no basis for assuming they were or are accurate.
...not all claims are valid or accurate...therefore officers fiduciary duty is to challenge when believed necessary. D&O does not cover those type of claims alleged and referenced ... and the discussion is all BS right now...especially since it will likely not be addressed for two years (or more with Covid).